Orders of prohibition relating to polymorphic form patent for PRISTIQ upheld on appeal

Published date02 March 2019
Law FirmSmart & Biggar
AuthorBrandon Heard
Subject MatterEvidence,Appeals,Obviousness,Prior Art,Hearsay,Dismissals,Trial Court Orders,Pharmaceutical Patents,Canada,Teva Pharmaceuticals,Reaffirmation,Apotex,Anticipation,Pharmaceutical Industry,Writ of Prohibition

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT